| Evolving changes in M-protein and hemoglobin as predictors for progression of smoldering multiple myeloma S Atrash, M Robinson, D Slaughter, A Aneralla, T Brown, J Robinson, ... Blood cancer journal 8 (11), 107, 2018 | 17 | 2018 |
| Validation of dynamic biomarker-based risk progression model for smoldering multiple myeloma S Atrash, MM Robinson, A Aneralla, T Brown, R Friend, C Sprouse, ... Blood 130, 1779, 2017 | 2 | 2017 |
| Prognostic significance of Ki67 expression by immunohistochemistry (IHC) on bone marrow biopsy in newly diagnosed multiple myeloma MM Robinson, S Atrash, T Brown, JG Block, EH Lipford, ET Smith, ... Blood 130, 4348, 2017 | 1 | 2017 |
| The (f) utility of therapy in ovarian cancer after the development of platinum resistance RW Naumann, S Trufan, A Aneralla, R Bose, EK Crane, DL Tait, ... Gynecologic Oncology 159, 105-106, 2020 | | 2020 |
| Towards Response-Adaptive Changes in Induction Therapy to Improve Survival Outcomes in Transplant Eligible Multiple Myeloma Patients T Brown, M Robinson, M Bhutani, P Voorhees, A Aneralla, R Bose, J Eddy, ... Clinical Lymphoma, Myeloma and Leukemia 17 (1), e59-e60, 2017 | | 2017 |
